PROPANC BIOPHARMA, INC. Total Long-Term Debt
PROPANC BIOPHARMA, INC. (PPCB) had Total Long-Term Debt of $55.00 thousand as of 2026-03-31, per its S-1 filed 2026-07-17.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2026-07-17
- 2026-03-31: Long-term Debt $55.00K.
- 2025-12-31: Long-term Debt $55.00K.
- 2025-09-30: Long-term Debt $106.97K.
- 2025-06-30: Long-term Debt $537.92K.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2026-03-31 | $55.00K S-1 · filed 2026-07-17 | |
| 2025-12-31 | $55.00K S-1 · filed 2026-04-10 | |
| 2025-09-30 | $106.97K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $537.92K S-1 · filed 2026-07-17 | |
| 2025-03-31 | $438.58K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $409.80K 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $381.79K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $399.32K S-1 · filed 2026-07-17 | |
| 2024-03-31 | $582.95K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $687.65K 10-Q · filed 2024-02-20 | |
| 2023-09-30 | $397.44K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $390.54K 10-K · filed 2024-09-30 | |
| 2023-03-31 | $519.72K 10-Q · filed 2023-05-15 | |
| 2022-09-30 | $913.64K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $926.44K 10-K · filed 2023-09-28 | $984.26K 10-K · filed 2022-09-28 |
| 2022-03-31 | $1.08M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $972.67K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $584.61K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $624.58K 10-K · filed 2022-09-28 | |
| 2021-03-31 | $950.18K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $1.21M 10-Q · filed 2021-02-12 | |
| 2020-09-30 | $1.03M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $1.56M 10-K · filed 2021-09-28 | |
| 2020-03-31 | $2.71M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $2.93M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $2.55M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.66M 10-K · filed 2020-10-01 | |
| 2019-03-31 | $2.07M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $2.79M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $3.76M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $4.70M 10-K · filed 2019-10-15 | |
| 2018-03-31 | $4.51M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $4.42M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $4.65M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $3.48M 10-K · filed 2018-09-17 | |
| 2017-03-31 | $2.65M 10-Q · filed 2017-05-08 | |
| 2016-06-30 | $1.20M 10-K · filed 2017-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |